Cantor Fitzgerald Predicts CATX FY2026 Earnings
Perspective Therapeutics, Inc. (NYSE:CATX – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2026 EPS estimates for Perspective Therapeutics in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst L. Watsek expects that the company will earn ($0.99) per share for the year. Cantor Fitzgerald has a […]
